Arkolith/Insider Trading/FTH/Form 4

Parikh Anand Kiran

President and CEO, DirectorFaeth Therapeutics, Inc. (FTH) · full profile →Form 4 · filed Jun 24, 2026
Net Buying
Open-Market Buys
$55K
Open-Market Sells
$0
Net Open-Market Flow
$55K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 22, 2026Buy(P)3K$19.76$55K764K
Jun 22, 2026Option exercise(M)45K$1.16$52K809K
Jun 22, 2026Option exercise(M)8K$1.16$10K818K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 22, 2026Option exercise(M)45K—$092K
Jun 22, 2026Option exercise(M)8K—$04K

Transaction Codes

P
Open-market purchase
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002111813-26-000010) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML